mifepristone has been researched along with Communicable Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, Y; Matsuwaki, T; Nishihara, M; Yamanouchi, K | 1 |
| Cleland, K; Creinin, MD; Nshom, M; Nucatola, D; Trussell, J | 1 |
2 other study(ies) available for mifepristone and Communicable Diseases
| Article | Year |
|---|---|
Glucocorticoids Suppress the Protective Effect of Cyclooxygenase-2-Related Signaling on Hippocampal Neurogenesis Under Acute Immune Stress.
Topics: Acute Disease; Animals; Communicable Diseases; Cyclooxygenase 2; Glucocorticoids; Hippocampus; Immunity, Cellular; Lipopolysaccharides; Male; Mifepristone; Neurogenesis; Rats; Rats, Wistar; Receptors, Glucocorticoid; Signal Transduction; Xanthones | 2017 |
Significant adverse events and outcomes after medical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Incomplete; Abortion, Induced; Anti-Bacterial Agents; Blood Transfusion; Communicable Diseases; Emergency Treatment; Evidence-Based Medicine; Female; Humans; Maternal Mortality; Mifepristone; Misoprostol; Patient Admission; Pregnancy; Pregnancy, Ectopic | 2013 |